GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annovis Bio Inc (FRA:07X) » Definitions » Interest Expense (Positive)

Annovis Bio (FRA:07X) Interest Expense (Positive)


View and export this data going back to 2020. Start your Free Trial

What is Annovis Bio Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.


Annovis Bio Business Description

Industry
Traded in Other Exchanges
Address
101 Lindenwood Drive, Suite 225, Malvern, PA, USA, 19355
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.